---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278928064.md"
description: "Indivior Pharmaceuticals shares are trading lower after the company announced its intention to commence a $400 million senior notes offering."
datetime: "2026-03-12T18:25:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278928064.md)
  - [en](https://longbridge.com/en/news/278928064.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278928064.md)
generator: "portal-rs"
---

# 

Indivior Pharmaceuticals shares are trading lower after the company announced its intention to commence a $400 million senior notes offering.

### Related Stocks

- [INDV.US](https://longbridge.com/en/quote/INDV.US.md)
- [INDV.UK](https://longbridge.com/en/quote/INDV.UK.md)

## Related News & Research

- [Indivior Q2 2026 Earnings Call: Complete Transcript](https://longbridge.com/en/news/296085674.md)
- [Indivior Chief Accounting Officer Woodrow D Anderson acquires 1,500 shares worth $54,420](https://longbridge.com/en/news/295014018.md)
- [Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19](https://longbridge.com/en/news/296655292.md)
- [Rhythm Pharmaceuticals Eyes AHO Growth, Global IMCIVREE Expansion and Pipeline Catalysts](https://longbridge.com/en/news/296061716.md)
- [Indivior Q2 FY26 GAAP net income rises to $122 million; revenue increases 14% to $343 million YoY](https://longbridge.com/en/news/294679226.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**